SLC22A2

SLC22A2 is a gene that encodes a protein known as the Organic Cation Transporter 2 (OCT2). This protein is a member of the solute carrier family of proteins, which are responsible for transporting various substances across the cell membrane.

Function

The SLC22A2 gene is primarily expressed in the kidney, where it plays a crucial role in the elimination of various endogenous and exogenous substances. The protein encoded by this gene is involved in the transport of organic cations, including various drugs and toxins. It is an important factor in drug disposition and response.

Clinical significance

Mutations in the SLC22A2 gene can lead to altered drug response and toxicity. For example, certain variants of this gene have been associated with increased risk of cisplatin nephrotoxicity. Furthermore, the SLC22A2 gene is a potential target for drug interactions, as many drugs are substrates for the OCT2 transporter.

Pharmacogenomics

The SLC22A2 gene is of interest in the field of pharmacogenomics, as variations in this gene can influence an individual's response to certain medications. For example, individuals with certain SLC22A2 variants may require different dosages of drugs that are substrates for the OCT2 transporter, such as metformin.

See also

• Solute carrier family
• Pharmacogenomics
• Drug metabolism

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian